![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Interactions Between ABT-493 plus ABT-530 combination and Rilpivirine or Raltegravir
|
|
|
Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
*Rajneet K. Oberoi1, *Matthew P. Kosloski1, Bifeng Ding1, Beibei Hu1, Stanley Wang1, Jens Kort1, Sandeep Dutta1, Wei Liu1 *Contributed equally to the abstract 1AbbVie Inc., North Chicago, Illinois, United States
![CROI1](../images/030116/030116-5/CROI1.gif)
![CROI2](../images/030116/030116-5/CROI2.gif)
![CROI3](../images/030116/030116-5/CROI3.gif)
![CROI4](../images/030116/030116-5/CROI4.gif)
![CROI5](../images/030116/030116-5/CROI5.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|